These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 34028524)

  • 1. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
    J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.
    Yamanouchi M; Mori M; Hoshino J; Kinowaki K; Fujii T; Ohashi K; Furuichi K; Wada T; Ubara Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000726. PubMed ID: 31798893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
    Huang B; Wen W; Ye S
    Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biomarkers for prognosticating diabetic kidney disease progression.
    Swaminathan SM; Rao IR; Shenoy SV; Prabhu AR; Mohan PB; Rangaswamy D; Bhojaraja MV; Nagri SK; Nagaraju SP
    Int Urol Nephrol; 2023 Apr; 55(4):913-928. PubMed ID: 36271990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.
    Shimizu M; Furuichi K; Kitajima S; Toyama T; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Miyagawa T; Hara A; Iwata Y; Sakai N; Kitagawa K; Yoshimura M; Yokoyama H; Wada T
    BMC Nephrol; 2021 Sep; 22(1):319. PubMed ID: 34560842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Chen S; Chen L; Jiang H
    Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease.
    Lee YH; Seo JW; Kim M; Tae D; Seok J; Kim YG; Lee SH; Kim JS; Hwang HS; Jeong KH; Moon JY
    Front Endocrinol (Lausanne); 2021; 12():774436. PubMed ID: 34858345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
    Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes.
    Looker HC; Lin C; Nair V; Kretzler M; Mauer M; Najafian B; Nelson RG
    Am J Kidney Dis; 2022 Apr; 79(4):497-506. PubMed ID: 34562525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
    Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I
    J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.